480 related articles for article (PubMed ID: 27631798)
21. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex.
Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC
J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249
[TBL] [Abstract][Full Text] [Related]
22. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
[TBL] [Abstract][Full Text] [Related]
23. High mobility group nucleosomal binding domain 2 (HMGN2) SUMOylation by the SUMO E3 ligase PIAS1 decreases the binding affinity to nucleosome core particles.
Wu J; Kim S; Kwak MS; Jeong JB; Min HJ; Yoon HG; Ahn JH; Shin JS
J Biol Chem; 2014 Jul; 289(29):20000-11. PubMed ID: 24872413
[TBL] [Abstract][Full Text] [Related]
24. Protection from isopeptidase-mediated deconjugation regulates paralog-selective sumoylation of RanGAP1.
Zhu S; Goeres J; Sixt KM; Békés M; Zhang XD; Salvesen GS; Matunis MJ
Mol Cell; 2009 Mar; 33(5):570-80. PubMed ID: 19285941
[TBL] [Abstract][Full Text] [Related]
25. In Vitro Characterization of Chain Depolymerization Activities of SUMO-Specific Proteases.
Eckhoff J; Dohmen RJ
Methods Mol Biol; 2016; 1475():123-35. PubMed ID: 27631802
[TBL] [Abstract][Full Text] [Related]
26. Dynamin interacts with members of the sumoylation machinery.
Mishra RK; Jatiani SS; Kumar A; Simhadri VR; Hosur RV; Mittal R
J Biol Chem; 2004 Jul; 279(30):31445-54. PubMed ID: 15123615
[TBL] [Abstract][Full Text] [Related]
27. Quantitative SUMO proteomics identifies PIAS1 substrates involved in cell migration and motility.
Li C; McManus FP; Plutoni C; Pascariu CM; Nelson T; Alberici Delsin LE; Emery G; Thibault P
Nat Commun; 2020 Feb; 11(1):834. PubMed ID: 32047143
[TBL] [Abstract][Full Text] [Related]
28. RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation cycle on Borealin.
Klein UR; Haindl M; Nigg EA; Muller S
Mol Biol Cell; 2009 Jan; 20(1):410-8. PubMed ID: 18946085
[TBL] [Abstract][Full Text] [Related]
29. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
Yang WS; Campbell M; Kung HJ; Chang PC
J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
[TBL] [Abstract][Full Text] [Related]
30. Pli1(PIAS1) SUMO ligase protected by the nuclear pore-associated SUMO protease Ulp1SENP1/2.
Nie M; Boddy MN
J Biol Chem; 2015 Sep; 290(37):22678-85. PubMed ID: 26221037
[TBL] [Abstract][Full Text] [Related]
31. The RanBP2/RanGAP1*SUMO1/Ubc9 complex: a multisubunit E3 ligase at the intersection of sumoylation and the RanGTPase cycle.
Flotho A; Werner A
Nucleus; 2012; 3(5):429-32. PubMed ID: 22925898
[TBL] [Abstract][Full Text] [Related]
32. ZNF451 is a novel PML body- and SUMO-associated transcriptional coregulator.
Karvonen U; Jääskeläinen T; Rytinki M; Kaikkonen S; Palvimo JJ
J Mol Biol; 2008 Oct; 382(3):585-600. PubMed ID: 18656483
[TBL] [Abstract][Full Text] [Related]
33. Alternative allosteric mechanisms can regulate the substrate and E2 in SUMO conjugation.
Karaca E; Tozluoğlu M; Nussinov R; Haliloğlu T
J Mol Biol; 2011 Mar; 406(4):620-30. PubMed ID: 21216249
[TBL] [Abstract][Full Text] [Related]
34. The Use of Multimeric Protein Scaffolds for Identifying Multi-SUMO Binding Proteins.
Aguilar-Martínez E; Sharrocks AD
Methods Mol Biol; 2016; 1475():195-204. PubMed ID: 27631807
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a novel posttranslational modification in neuronal nitric oxide synthase by small ubiquitin-related modifier-1.
Watanabe M; Itoh K
Biochim Biophys Acta; 2011 Jul; 1814(7):900-7. PubMed ID: 21545853
[TBL] [Abstract][Full Text] [Related]
36. BS69 undergoes SUMO modification and plays an inhibitory role in muscle and neuronal differentiation.
Yu B; Shao Y; Zhang C; Chen Y; Zhong Q; Zhang J; Yang H; Zhang W; Wan J
Exp Cell Res; 2009 Dec; 315(20):3543-53. PubMed ID: 19766626
[TBL] [Abstract][Full Text] [Related]
37. PIASγ controls stability and facilitates SUMO-2 conjugation to CoREST family of transcriptional co-repressors.
Sáez JE; Arredondo C; Rivera C; Andrés ME
Biochem J; 2018 Apr; 475(8):1441-1454. PubMed ID: 29555846
[TBL] [Abstract][Full Text] [Related]
38. Small ubiquitin-like modifier 1-3 conjugation [corrected] is activated in human astrocytic brain tumors and is required for glioblastoma cell survival.
Yang W; Wang L; Roehn G; Pearlstein RD; Ali-Osman F; Pan H; Goldbrunner R; Krantz M; Harms C; Paschen W
Cancer Sci; 2013 Jan; 104(1):70-7. PubMed ID: 23078246
[TBL] [Abstract][Full Text] [Related]
39. SUMO E3 ligases are expressed in the retina and regulate SUMOylation of the metabotropic glutamate receptor 8b.
Dütting E; Schröder-Kress N; Sticht H; Enz R
Biochem J; 2011 Apr; 435(2):365-71. PubMed ID: 21288202
[TBL] [Abstract][Full Text] [Related]
40. Analysis of Histone Deacetylases Sumoylation by Immunoprecipitation Techniques.
Wagner T; Godmann M; Heinzel T
Methods Mol Biol; 2017; 1510():339-351. PubMed ID: 27761833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
